Pfizer: Onychomycosis trials
The registry lists 11 Onychomycosis studies with Pfizer as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 1Phase 2 7Phase 3 2Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and AdolescentsCompletedNCT03405818Phase 4Results posted
- Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedNCT01302119Phase 3Results posted
- Safety and Efficacy Study of Subjects With Onychomycosis of the Great ToenailCompletedNCT01278394Phase 2Results posted
- Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the ToenailCompletedNCT01270971Phase 3Results posted
- Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)CompletedNCT00680160Phase 2
- Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With OnychomycosisCompletedNCT00680134Phase 2
- Cumulative Irritation TestCompletedNCT00680095Phase 1
- Study of Different Doses of a Novel Treatment for OnychomycosisCompletedNCT00679965Phase 2
- Study of Different Doses of a Novel Treatment for OnychomycosisCompletedNCT00679770Phase 2
- Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)CompletedNCT00679601Phase 2
- Safety and Efficacy Study of Subjects With Onychomycosis of the Great ToenailCompletedNCT00679523Phase 2